|
 |
| Mailing List Information and Details
|
|
 |
|
 |
IMGENEX Exclusive North America Distribu |
 |
| |
| Title |
|
IMGENEX Exclusive North America Distribu |
| Overview |
|
SanDiego,CA- August 25, 2007 – IMGENEX is pleased to announce that it has signed |
| Category |
|
Science / Biology |
| Grade |
|
Grade 1 List (0 - 100 subscribers) |
| Language |
|
English |
| Date Added |
|
13 Sep 2007 |
| List Info URL |
|
http://www.imgenex.com |
| Description |
|
SanDiego,CA- August 25, 2007 - IMGENEXis pleased to announce that it has signed an exclusive distribution agreement with Dendritics SAS (Dardilly, France) to make their portfolio of highly characterized and validated monoclonal Dendritic cell research antibodies available to researchers in North America and India. Founded in 2005, the goal of Dendritics SAS was to make their technology and expertise available to the commercial market where other researchers could benefit from these innovative reagents. Dendritics’ reagents have been validated and reported in many peer reviewed publications and can be used in flow cytometric analysis, IHC, cell depletion and blocking assays. All antibodies are purified and most are available in a multiple formats.
Dendritics SAS research reagents are categorized into six major research focus areas: Dendritic Cell (DC) subtypes, C-type Lectin Receptors (CLRs),T |
| |
 |
 |
|
|
 |
|
 |
|
|
|
|
|
|